Rosenstock J, Wysham C, Fras JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
However, the -helical content decreased from 49.07% to 43.75% at 60C and further to 0.2% at 80C, indicating extensive conformational transitions at elevated temperatures that compromise receptor binding and in vivo performance
Reconstitute the HCG powder with the provided bacteriostatic water, draw up the prescribed dose and inject it subcutaneously in the lower abdomen, thigh or upper arm
This risk is very real
Avoiding High-Stakes Days Never inject before important events, presentations, travel, or social occasions you do not want to miss